The debate about the opportunity of legalization has often been characterized by two positions: Some Medical practitioners and wellbeing gurus warn in opposition to trivializing cannabis. Neurologist Euphrosyne Gouzoulis-Mayfrank, incoming president on the German Modern society for Psychiatry, Psychotherapy and Psychosomatics (DGPPN), has mentioned